Similar articles

• Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression.

  Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R, Bevilacqua G. Fontanini G, et al. J Pathol. 1994 Sep;174(1):23-31. doi: 10.1002/path.1711740105. J Pathol. 1994. PMID: 7965400
• Loss of FHIT function in lung cancer and preinvasive bronchial lesions.

  Sozzi G, Pastorino U, Moiraghi L, Tagliabue E, Pezzella F, Ghirelli C, Tornielli S, Sard L, Huebner K, Pierotti MA, Croce CM, Pilotti S. Sozzi G, et al. Cancer Res. 1998 Nov 15;58(22):5032-7. Cancer Res. 1998. PMID: 9823304
• p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer.

  Brambilla E, Gazzeri S, Lantuejoul S, Coll JL, Moro D, Negoescu A, Brambilla C. Brambilla E, et al. Clin Cancer Res. 1998 Jul;4(7):1609-18. Clin Cancer Res. 1998. PMID: 9676834
• Nuclear p53 overexpression is an independent prognostic parameter in node-negative non-small cell lung carcinoma.

  Dalquen P, Sauter G, Torhorst J, Schultheiss E, Jordan P, Lehmann S, Solèr M, Stulz P, Mihatsch MJ, Gudat F. Dalquen P, et al. J Pathol. 1996 Jan;178(1):53-8. doi: 10.1002/(SICI)1096-9896(199601)178:1<53::AID-PATH415>3.0.CO;2-T. J Pathol. 1996. PMID: 8778317 Review.
• Cytogenetics and molecular genetics of lung cancer.

  Mitsuuchi Y, Testa JR. Mitsuuchi Y, et al. Am J Med Genet. 2002 Oct 30;115(3):183-8. doi: 10.1002/ajmg.10692. Am J Med Genet. 2002. PMID: 12407699 Review.